Impact of intensive treatment on serum methylglyoxal levels among individuals with screen-detected type 2 diabetes: the ADDITION-Denmark study
Methylglyoxal (MG) has been implicated in the development of micro- and macrovascular diabetic complications, but it remains unclear how current treatments of type 2 diabetes affect its circulating levels.
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
27 March 2015
|
| In: |
Acta diabetologica
Year: 2015, Volume: 52, Issue: 5, Pages: 929-936 |
| ISSN: | 1432-5233 |
| DOI: | 10.1007/s00592-015-0739-7 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00592-015-0739-7
|
| Author Notes: | Troels M. Jensen, Dorte Vistisen, Thomas Fleming, Peter P. Nawroth, Marit E. Jørgensen, Torsten Lauritzen, Annelli Sandbæk, Daniel R. Witte |
| Summary: | Methylglyoxal (MG) has been implicated in the development of micro- and macrovascular diabetic complications, but it remains unclear how current treatments of type 2 diabetes affect its circulating levels. |
|---|---|
| Item Description: | Gesehen am 19.06.2020 |
| Physical Description: | Online Resource |
| ISSN: | 1432-5233 |
| DOI: | 10.1007/s00592-015-0739-7 |